Related Experiment Video

Updated: Jun 13, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Spectrum of head and neck cancer in children

Subhabrata Sengupta1, Ranabir Pal, Somnath Saha

  • 1Department of Oto-Rhino-Laryngology, Sikkim-Manipal Institute of Medical Sciences (SMIMS) and Central Referral Hospital (CRH), 5th Mile Tadong, Gangtok, Sikkim-737 102, India.

Journal of Indian Association of Pediatric Surgeons
|April 27, 2010
PubMed

Insights

Pediatric head and neck cancers are rare, with lymphomas being the most common malignancy in children under 12. This study highlights the importance of considering malignancy in pediatric head and neck masses.

Area of Science:

  • Pediatric Oncology
  • Otolaryngology
  • Head and Neck Surgery

Background:

  • Head and neck cancers are uncommon in children.
  • Early diagnosis and treatment are crucial for better outcomes.

Purpose of the Study:

  • To determine the incidence of various head and neck cancers in pediatric patients.
  • To identify the most prevalent types of head and neck neoplasms in this age group.

Main Methods:

  • Prospective study involving children under 12 years.
  • Comprehensive clinical and ENT examinations.
  • Histological confirmation of all diagnoses.

Main Results:

  • 53 cases of head and neck neoplasms identified in 21,216 children (0.25% incidence).
  • Lymphomas were the most frequent (43.39%), followed by rhabdomyosarcoma (20.75%) and nasopharyngeal carcinoma (15.09%).
  • Non-Hodgkin's lymphoma constituted the majority of lymphoma cases (26.41%).

Conclusions:

  • Malignancy should be a key consideration in the differential diagnosis of pediatric head and neck masses.
  • Prompt evaluation is essential for timely intervention in suspected pediatric head and neck cancers.
Abstract

Keywords:
Head and neck tumorlymphomarhabdomyosarcoma

More Related Videos

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...